Nikolaos Grigoriadis Selected Research

Multiple Sclerosis

7/2023	Epidemiological Insights on Medication Concurrency and Polypharmacy in People With Multiple Sclerosis in Greece.
5/2023	The Diversity of Astrocyte Activation during Multiple Sclerosis: Potential Cellular Targets for Novel Disease Modifying Therapeutics.
1/2023	How does Nogo receptor influence demyelination and remyelination in the context of multiple sclerosis?
1/2023	A Prospective, Observational Study Assessing Effectiveness, Safety, and QoL of Greek Patients with Multiple Sclerosis Under Treatment with Fingolimod.
1/2023	Nogo receptor-Fc delivered by haematopoietic cells enhances neurorepair in a multiple sclerosis model.
12/2022	Diagnosis and classification of optic neuritis.
11/2022	Modulation of the Microglial Nogo-A/NgR Signaling Pathway as a Therapeutic Target for Multiple Sclerosis.
1/2022	Anti-SARS-CoV-2 vaccination in people with multiple sclerosis: Lessons learnt a year in.
1/2022	Phase III, randomised, double-blind, placebo-controlled trial of Neuroaspis plp10 as an adjuvant treatment for relapsing multiple sclerosis: the MINERAL Study.
11/2021	Signaling through the S1P-S1PR Axis in the Gut, the Immune and the Central Nervous System in Multiple Sclerosis: Implication for Pathogenesis and Treatment.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nikolaos Grigoriadis Research Topics

Disease

33	Multiple Sclerosis 07/2023 - 07/2007
19	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 03/2024 - 12/2003
17	Inflammation (Inflammations) 05/2024 - 01/2005
15	Relapsing-Remitting Multiple Sclerosis 01/2023 - 07/2002
12	Demyelinating Diseases (Demyelinating Disease) 07/2023 - 12/2009
12	Neuroinflammatory Diseases 01/2023 - 03/2006
8	Stroke (Strokes) 10/2022 - 08/2008
8	Tauopathies 01/2022 - 10/2006
8	Alzheimer Disease (Alzheimer's Disease) 01/2019 - 10/2006
7	Traumatic Brain Injuries (Traumatic Brain Injury) 10/2013 - 03/2006
6	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2024 - 10/2006
5	Atrophy 04/2024 - 01/2002
5	Infections 03/2024 - 01/2009
5	Neoplasms (Cancer) 07/2023 - 01/2003
5	Gliosis 01/2023 - 10/2006
5	Disease Progression 11/2020 - 06/2008
4	Neuromyelitis Optica (Devic's Disease) 12/2022 - 03/2010
4	Brain Diseases (Brain Disorder) 01/2021 - 04/2008
4	Encephalitis (Encephalitis, Rasmussen) 08/2010 - 12/2003
4	Closed Head Injuries 12/2009 - 03/2006
3	Obesity 03/2024 - 01/2023
3	COVID-19 01/2023 - 01/2021
3	Fatigue 02/2022 - 10/2004
3	Wounds and Injuries (Trauma) 12/2009 - 07/2007
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 03/2024 - 02/2017
2	Encephalomyelitis (Myeloencephalitis) 10/2023 - 02/2006
2	Autism Spectrum Disorder 05/2023 - 06/2019
2	Nervous System Diseases (Neurological Disorders) 01/2023 - 10/2013
2	Chronic Progressive Multiple Sclerosis 01/2022 - 01/2020
2	Neurologic Manifestations (Neurological Manifestations) 09/2021 - 10/2006
2	Progressive Multifocal Leukoencephalopathy 01/2021 - 08/2011
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021 - 02/2017
2	Cognitive Dysfunction 06/2020 - 01/2017
2	Autistic Disorder (Autism) 01/2020 - 01/2019
2	Pathologic Processes 01/2018 - 01/2017
2	Thrombosis (Thrombus) 01/2015 - 01/2015
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 09/2014 - 08/2008
2	Prion Diseases (Transmissible Spongiform Encephalopathies) 01/2013 - 07/2009
2	Dementia (Dementias) 07/2011 - 03/2009
2	Autoimmune Diseases (Autoimmune Disease) 12/2009 - 01/2005
2	Scrapie 07/2009 - 10/2006
2	Central Nervous System Diseases (CNS Diseases) 07/2007 - 12/2003
1	Cerebellar Diseases (Cerebellar Syndrome) 05/2024
1	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 05/2024
1	Muscular Atrophy (Muscle Atrophy) 05/2024
1	Hyperhomocysteinemia 03/2024
1	Dysbiosis 03/2024
1	Atrial Fibrillation 03/2024
1	Hypertension (High Blood Pressure) 03/2024
1	Atherosclerosis 03/2024
1	Dyslipidemias (Dyslipidemia) 03/2024
1	Diabetes Mellitus 03/2024
1	Insulin Resistance 03/2024
1	Mood Disorders (Mood Disorder) 07/2023

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 05/2024 - 01/2007
7	Biomarkers (Surrogate Marker)IBA 12/2022 - 01/2019
6	Peptides (Polypeptides)IBA 01/2019 - 01/2005
5	AntibodiesIBA 05/2024 - 07/2009
4	Nogo ReceptorsIBA 01/2023 - 10/2016
4	LigandsIBA 01/2023 - 01/2005
4	Natalizumab (Tysabri)FDA Link 01/2021 - 08/2011
4	Amyloid (Amyloid Fibrils)IBA 07/2011 - 10/2006
3	Galectin 3 (LGALS3)IBA 03/2024 - 01/2020
3	VaccinesIBA 01/2023 - 01/2021
3	Fingolimod Hydrochloride (FTY720)FDA Link 01/2023 - 01/2016
3	Neutralizing AntibodiesIBA 01/2023 - 01/2016
3	ChemokinesIBA 12/2022 - 12/2015
3	CytokinesIBA 12/2022 - 07/2011
3	nitazoxanide (NTZ)FDA Link 01/2021 - 01/2016
3	tau Proteins (tau Protein)IBA 10/2013 - 10/2006
3	AntigensIBA 07/2007 - 01/2005
2	Nogo Receptor 1IBA 01/2023 - 01/2021
2	EnzymesIBA 01/2023 - 09/2021
2	Complement C5 (Complement 5)IBA 01/2023 - 01/2023
2	Complement System Proteins (Complement)IBA 01/2023 - 01/2023
2	Myelin-Oligodendrocyte GlycoproteinIBA 12/2022 - 11/2020
2	Retinaldehyde (Retinal)IBA 12/2022 - 07/2022
2	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 02/2022 - 06/2021
2	InterferonsIBA 01/2022 - 01/2016
2	Immunoglobulin G (IgG)IBA 02/2021 - 01/2009
2	Metalloproteases (Metalloproteinases)IBA 07/2019 - 02/2018
2	Caspase 3 (Caspase-3)IBA 11/2018 - 12/2009
2	LectinsIBA 01/2018 - 03/2009
2	Interferon-betaIBA 01/2016 - 07/2002
2	Prion ProteinsIBA 01/2013 - 07/2009
2	Therapeutic UsesIBA 07/2011 - 01/2011
2	DNA (Deoxyribonucleic Acid)IBA 07/2007 - 03/2006
2	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2007 - 03/2006
1	LipopolysaccharidesIBA 05/2024
1	StathminIBA 03/2024
1	Indicators and Reagents (Reagents)IBA 03/2024
1	AdipokinesIBA 03/2024
1	Lipoprotein(a)IBA 03/2024

Therapy/Procedure

20	Therapeutics 07/2023 - 03/2007
8	Transplantation 01/2022 - 12/2003
6	Immunomodulation 10/2023 - 06/2008
5	Immunotherapy 07/2023 - 10/2006
3	Cognitive Training 06/2020 - 01/2017
2	Denervation 01/2003 - 01/2002
1	Polypharmacy 07/2023